IBB241227C151000
- 0.00
- 0.000.00%
iShares Biotechnology ETF Newsroom
Looking At Amgen's Recent Unusual Options Activity
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Markets Sluggishly Move to Year-End
Medical stocks welcome a rebound opportunity: three major star companies may become investment highlights in 2025.
In 2024, the performance of the Medical Industry is disappointing for investors, but 2025 may bring a glimmer of hope.
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Sector Update: Health Care Stocks Steady Premarket Thursday
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Exchange-Traded Funds, US Equities Higher in Tuesday's Shortened Trading
Sector Update: Health Care Stocks Mixed Premarket Tuesday
How Is The Market Feeling About Alnylam Pharmaceuticals?
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More
Waters Analyst Ratings
Sector Update: Health Care Stocks Fall Premarket Monday
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today